Home>APIs>

Doxofylline

CAS number: 69975-86-6

Molecular formula: C11H14N4O4

molecular weight: 266.26

Chemical structure:

Producers shown on SFDA

(Record date:11/10/2021)

Producer

Documents

GMP Valid till(based on SFDA)

Zhejiang Anglikang Pharmaceutical Co., Ltd.

GMP
Valid till March 2020

Zhejiang Changming Pharmaceutical Co., Ltd.

GMP
Valid till February 2024

Fu'an Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.

GMP
Valid till July 2023

Hansheng Pharmaceutical Co., Ltd.

GMP
Valid till May 2023

Liaoning Yaolian Pharmaceutical Co., Ltd. 

GMP
Valid till February 2024

Heilongjiang Fuhe Huaxing Pharmaceutical Group Co., Ltd.

GMP
Valid till February 2022


Producers shown on EP

Not showing any

Producer:Zhejiang Anglikang Pharmaceutical Co., Ltd., established in December 2001, is mainly engaged in the R & D, production and sales of chemical APIs and preparations. It owns a holding subsidiary of Liujia. A perfect quality management system has been established, covering the whole process from product R & D, raw and auxiliary material procurement, production and quality control, warehousing, product distribution to sales tracking, and the company's internal control quality standards higher than the national legal standards have been formulated in accordance with GMP specifications to ensure product quality.

Staff size:About 900 persons

Registered capital:RMB 95 million 950 thousand


Producer:Zhejiang Changming Pharmaceutical Co., Ltd. has a registered capital of 50 million yuan, covers an area of more than 90 Mu and employs more than 250 people,

It has a modern workshop in line with GMP standards, and has passed the new domestic GMP certification, FDA review, EU official review, ISO9001 quality management system certification, ISO14001 environmental management system certification and OHSAS18000 occupational health and safety management system certification.

Staff size:200-299 persons

Registered capital:RMB 50 million


Producer:Fu'an Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., a subsidiary of Fu'an Pharmaceutical (Group) Co., Ltd., is the production base of antitumor API of the group. Founded in August 1992, Tianheng has been engaged in the pharmaceutical industry for more than 20 years and has fully passed the national GMP certification. The enterprise has national first-class medical science and technology strength and medical science and technology research center.

Staff size:400-499 persons

Registered capital:RMB 415 million


Producer:Hansheng Pharmaceutical Co., Ltd.registered in 1996 with a registered capital of 80 million yuan, is also the first genetic engineering product manufacturer in China to pass GMP certification. The company covers an area of 263 Mu and a construction area of more than 50000 square meters. The company has 5 GMP certified production lines.

Staff size:100-199 persons

Registered capital:RMB 80 million 


Producer:Liaoning Yaolian Pharmaceutical Co., Ltd. was established in 2008, covering an area of about 90000 square meters, including water needle workshop, freeze-dried powder workshop, solid preparation workshop, raw material synthesis workshop, hormone and anti-cancer workshop, laboratory and relevant auxiliary facilities. The total investment is 350 million yuan, the designed production capacity is 100 million injections and more than 1 billion boxes of solid preparations, which can form an output value of 10 billion yuan / year after full delivery.

Staff size:200-299 persons

Registered capital:RMB 110 million


Producer:Heilongjiang Fuhe Pharmaceutical Group Co., Ltd. (formerly Heilongjiang Fuhe Huaxing Pharmaceutical Group Co., Ltd.) is subordinate to Fuhe group. The production base covers an area of 312000 square meters. The company has dozens of dosage forms and 150 varieties such as tablets, injections, capsules and APIs. Fuhe Huaxing Industrial Park
The annual output is 500 million capsules, 50 million bottles of oral liquid, 100 million bags of granules and 20 million bottles of freeze-dried powder injection.
Staff size:300-399 persons

Registered capital:RMB 229.3 million


For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978